Nancy A Rigotti1, Hilary A Tindle2, Susan Regan3, Douglas E Levy4, Yuchiao Chang5, Kelly M Carpenter6, Elyse R Park7, Jennifer H K Kelley8, Joanna M Streck9, Zachary Z Reid8, Thomas Ylioja10, Michele Reyen11, Daniel E Singer5. 1. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts; Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts. Electronic address: nrigotti@partners.org. 2. Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. 3. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts; Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts. 4. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts. 5. Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts. 6. Alere Wellbeing, Inc., Seattle, Washington. 7. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. 8. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston, Massachusetts. 9. Department of Psychological Science, University of Vermont, Burlington, Vermont. 10. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 11. Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, Massachusetts; Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Abstract
INTRODUCTION: Hospitalization provides an opportunity for smokers to quit, but tobacco-cessation interventions started in hospital must continue after discharge to be effective. This study aimed to improve the scalability of a proven effective post-discharge intervention by incorporating referral to a telephone quitline, a nationally available cessation resource. STUDY DESIGN: A three-site RCT compared Sustained Care, a post-discharge tobacco-cessation intervention, with Standard Care among hospitalized adult smokers who wanted to quit smoking and received in-hospital tobacco-cessation counseling. SETTING/PARTICIPANTS: A total of 1,357 daily smokers admitted to three hospitals were enrolled from December 2012 to July 2014. INTERVENTION: Sustained Care started at discharge and included automated interactive voice response telephone calls and the patient's choice of cessation medication for 3 months. Each automated call advised cessation, supported medication adherence, and triaged smokers seeking additional counseling or medication support directly to a telephone quitline. Standard Care provided only medication and counseling recommendations at discharge. MAIN OUTCOME MEASURES: Biochemically confirmed past 7-day tobacco abstinence 6 months after discharge (primary outcome) and self-reported tobacco abstinence and tobacco-cessation treatment use at 1, 3, and 6 months and overall (0-6 months). Analyses were done in 2015-2016. RESULTS: Smokers offered Sustained Care (n=680), versus those offered Standard Care (n=677), did not have greater biochemically confirmed abstinence at 6 months (17% vs 16%, p=0.58). However, the Sustained Care group reported more tobacco-cessation counseling and medication use at each follow-up and higher rates of self-reported past 7-day tobacco abstinence at 1 month (43% vs 32%, p<0.0001) and 3 months (37% vs 30%, p=0.008). At 6 months, the difference narrowed (31% vs 27%, p=0.09). Overall, the intervention increased self-reported 7-day abstinence over the 6-month follow-up (relative risk, 1.25; 95% CI=1.10, 1.40; p=0.0006). CONCLUSIONS: A 3-month post-discharge smoking-cessation intervention for hospitalized smokers who wanted to quit did not increase confirmed tobacco abstinence at 6 months but did increase self-reported abstinence during the treatment period (3 months). Real-time linkage of interactive voice response calls to a quitline, done in this trial to increase scalability of a previously proven cessation intervention, demonstrated short-term promise but did not sustain long-term intervention effectiveness. TRIAL REGISTRATION: This study is registered at www.clinicaltrials.gov NCT01714323.
RCT Entities:
INTRODUCTION: Hospitalization provides an opportunity for smokers to quit, but tobacco-cessation interventions started in hospital must continue after discharge to be effective. This study aimed to improve the scalability of a proven effective post-discharge intervention by incorporating referral to a telephone quitline, a nationally available cessation resource. STUDY DESIGN: A three-site RCT compared Sustained Care, a post-discharge tobacco-cessation intervention, with Standard Care among hospitalized adult smokers who wanted to quit smoking and received in-hospital tobacco-cessation counseling. SETTING/PARTICIPANTS: A total of 1,357 daily smokers admitted to three hospitals were enrolled from December 2012 to July 2014. INTERVENTION: Sustained Care started at discharge and included automated interactive voice response telephone calls and the patient's choice of cessation medication for 3 months. Each automated call advised cessation, supported medication adherence, and triaged smokers seeking additional counseling or medication support directly to a telephone quitline. Standard Care provided only medication and counseling recommendations at discharge. MAIN OUTCOME MEASURES: Biochemically confirmed past 7-day tobacco abstinence 6 months after discharge (primary outcome) and self-reported tobacco abstinence and tobacco-cessation treatment use at 1, 3, and 6 months and overall (0-6 months). Analyses were done in 2015-2016. RESULTS: Smokers offered Sustained Care (n=680), versus those offered Standard Care (n=677), did not have greater biochemically confirmed abstinence at 6 months (17% vs 16%, p=0.58). However, the Sustained Care group reported more tobacco-cessation counseling and medication use at each follow-up and higher rates of self-reported past 7-day tobacco abstinence at 1 month (43% vs 32%, p<0.0001) and 3 months (37% vs 30%, p=0.008). At 6 months, the difference narrowed (31% vs 27%, p=0.09). Overall, the intervention increased self-reported 7-day abstinence over the 6-month follow-up (relative risk, 1.25; 95% CI=1.10, 1.40; p=0.0006). CONCLUSIONS: A 3-month post-discharge smoking-cessation intervention for hospitalized smokers who wanted to quit did not increase confirmed tobacco abstinence at 6 months but did increase self-reported abstinence during the treatment period (3 months). Real-time linkage of interactive voice response calls to a quitline, done in this trial to increase scalability of a previously proven cessation intervention, demonstrated short-term promise but did not sustain long-term intervention effectiveness. TRIAL REGISTRATION: This study is registered at www.clinicaltrials.gov NCT01714323.
Authors: Jack F Hollis; Timothy A McAfee; Jeffrey L Fellows; Susan M Zbikowski; Michael Stark; Karen Riedlinger Journal: Tob Control Date: 2007-12 Impact factor: 7.552
Authors: Robert D Reid; Kerri-Anne Mullen; Monika E Slovinec D'Angelo; Debbie A Aitken; Sophia Papadakis; Patricia M Haley; Christine A McLaughlin; Andrew L Pipe Journal: Nicotine Tob Res Date: 2009-11-10 Impact factor: 4.244
Authors: Nancy A Rigotti; Susan Regan; Douglas E Levy; Sandra Japuntich; Yuchiao Chang; Elyse R Park; Joseph C Viana; Jennifer H K Kelley; Michele Reyen; Daniel E Singer Journal: JAMA Date: 2014-08-20 Impact factor: 56.272
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Nancy A Rigotti; Yuchiao Chang; Lisa C Rosenfeld; Sandra J Japuntich; Elyse R Park; Hilary A Tindle; Douglas E Levy; Zachary Z Reid; Joanna Streck; Timothy Gomperts; Jennifer H K Kelley; Daniel E Singer Journal: J Gen Intern Med Date: 2017-06-14 Impact factor: 5.128
Authors: Joanna M Streck; Susan Regan; Yuchiao Chang; Jennifer H K Kelley; Daniel E Singer; Nancy A Rigotti Journal: Drug Alcohol Depend Date: 2017-07-08 Impact factor: 4.492
Authors: Gina R Kruse; Vaibhav Thawal; Himanshu A Gupte; Leni Chaudhuri; Sultan Pradhan; Sydney Howard; Nancy A Rigotti Journal: Nicotine Tob Res Date: 2020-03-16 Impact factor: 4.244
Authors: Denise S Taylor; Dominique Medaglio; Claudine T Jurkovitz; Freda Patterson; Zugui Zhang; Adebayo Gbadebo; Elisabeth Bradley; Rose Wessells; Edward Goldenberg Journal: Nicotine Tob Res Date: 2020-03-16 Impact factor: 4.244
Authors: Joanna M Streck; Yuchiao Chang; Hilary A Tindle; Susan Regan; Elyse R Park; Douglas E Levy; Daniel E Singer; Thomas Ylioja; Nancy A Rigotti Journal: J Hosp Med Date: 2018-08-29 Impact factor: 2.960
Authors: Virginia A Triant; Ellie Grossman; Nancy A Rigotti; Rekha Ramachandran; Susan Regan; Scott E Sherman; Kimber P Richter; Hilary A Tindle; Kathleen F Harrington Journal: Nicotine Tob Res Date: 2020-06-12 Impact factor: 4.244
Authors: Nancy A Rigotti; Yuchiao Chang; Hilary A Tindle; Sara M Kalkhoran; Douglas E Levy; Susan Regan; Jennifer H K Kelley; Esa M Davis; Daniel E Singer Journal: Ann Intern Med Date: 2018-03-27 Impact factor: 25.391
Authors: Titus Josef Brinker; Christian Martin Brieske; Stefan Esser; Joachim Klode; Ute Mons; Anil Batra; Tobias Rüther; Werner Seeger; Alexander H Enk; Christof von Kalle; Carola Berking; Markus V Heppt; Martina V Gatzka; Breno Bernardes-Souza; Richard F Schlenk; Dirk Schadendorf Journal: J Med Internet Res Date: 2018-08-15 Impact factor: 5.428
Authors: Steven L Bernstein; June Weiss; Michelle DeWitt; Jeanette M Tetrault; Allen L Hsiao; James Dziura; Scott Sussman; Ted Miller; Kelly Carpenter; Patrick O'Connor; Benjamin Toll Journal: Implement Sci Date: 2019-01-22 Impact factor: 7.327